BRIEF-Theratechnologies announces commercialization agreement for Tesamorelin in Spain and Portugal

Thu Sep 1, 2016 12:37pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Sept 1 (Reuters) -

* Theratechnologies announces commercialization agreement for Tesamorelin in Spain and Portugal

* Theratechnologies-will manufacture and supply EGRIFTA to Praxis at a predetermined transfer price

* Theratechnologies-concluded agreements With Praxis Pharmaceutical, S.A. and its unit for distribution,commercialization of EGRIFTA in Spain and Portugal

* Theratechnologies-Praxis to conduct regulatory activities necessary for marketing approval for EGRIFTA in Spain ,Portugal

* Theratechnologies-Praxis will distribute EGRIFTA through named patient sales programs Source text for Eikon: